Live feed
·
PRReleasevia Quantisnow
Niagen Bioscience Inc. logo

Niagen Bioscience Acquires Existing Core Nicotinamide Riboside (NR) Patent Portfolio from Queen's University Belfast

ByQuantisnow·Wall Street's wire, on your screen.
NAGE· Niagen Bioscience Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NAGE (Niagen Bioscience Inc.) and more on Quantisnow.